Company Monitoring Page for Sanofi

latest headlines for company on cafepharma

Sanofi's CDMO spinoff set for next month as new group targets 2022 revenues of €1B
Fierce Pharma
Fri, 04/1/22 - 10:32 am
Tags:
Sanofi, spinoffs, Europe, API, CDMO, EuroAPI
Sanofi in the News: Grand Expectations and Paul Hudson's $12.3M Salary
BioSpace
Thu, 03/31/22 - 11:26 pm
Tags:
Sanofi, Paul Hudson, Pharma CEOs, IGM Biosciences, executive pay
Sanofi Commits Potential $6B to IGM (Antibodies) in New Collab
BioSpace
Tue, 03/29/22 - 10:53 am
Tags:
Sanofi, IGM Biosciences, oncology, immunology, antibodies, drug discovery, cancer
Big pharma’s key second-quarter data
EP Vantage
Tue, 03/29/22 - 10:32 am
Tags:
Roche, tiragolumab, Giredestrant, Sanofi, Eli Lilly, tirzepatide, Novo Nordisk, GSK, Pfizer, RSV
Sanofi's Xenpozyme gets approval in Japan for rare genetic disease
Seeking Alpha
Mon, 03/28/22 - 10:30 am
Tags:
Sanofi, Xenpozyme, Japan, ASMD
Lilly, after making $1B bet, posts 'compelling' late-phase data on Dupixent rival
Fierce Biotech
Mon, 03/28/22 - 10:20 am
Tags:
Eli Lilly, lebrikizumab, Demira, Sanofi, Regeneron, Dupixent, atopic dermatitis
Synthetic Antibodies to be Designed with Organoids
Science & Enterprise
Tue, 03/22/22 - 11:13 pm
Tags:
antibodies, synthetic antibodies, organoids, Prellis Biologics, Sanofi
Sanofi preps API spinoff for Paris exchange listing, shareholders reap dividend
Endpoints
Sun, 03/20/22 - 10:59 pm
Tags:
Sanofi, API, spinoffs, Paris, EuroAPI
Sanofi steps off the sidelines to ink 3 ADC deal with Seagen, reigniting long-held interest in the modality
Fierce Biotech
Wed, 03/16/22 - 10:38 am
Tags:
Sanofi, Seagen, antibody-drug conjugate, cancer, oncology
Playing catch-up with J&J, Sanofi taps Blackstone for $300M to fund pivotal trial of subcutaneous Sarclisa
Fierce Pharma
Tue, 03/15/22 - 10:47 am
Tags:
Sanofi, Blackstone Life Sciences, Sarclisa, Multiple Myeloma
Long wait for pivotal data on Sanofi's oral SERD ends in failure
Fierce Biotech
Mon, 03/14/22 - 10:32 am
Tags:
Sanofi, Amcenestrant, Serds, breast cancer, clinical trials
Sanofi Unites Under a Single Purpose at Cambridge Crossing
BioSpace
Mon, 03/14/22 - 10:29 am
Tags:
Sanofi, headquarters, Cambridge, Sanofi Pasteur, Sanofi Genzyme
Sanofi, scarred by Roche scrap, hits goal in once-weekly hemophilia A trial and plots race to regulators
Fierce Biotech
Wed, 03/9/22 - 10:54 am
Tags:
Sanofi, Roche, Sobi, hemophilia A, clinical trials
Pressing for label change, vaccine giant Sanofi takes Seqirus influenza imbroglio to the FDA
Fierce Pharma
Wed, 03/9/22 - 10:50 am
Tags:
Sanofi, Seqirus, vaccines, flu vaccines
Going All In on mRNA, Sanofi Breaks Ground on New Vaccine Site
BioSpace
Tue, 03/8/22 - 10:03 am
Tags:
Sanofi, vaccines, MRNA, drug manufacturing
Sanofi, AstraZeneca Express Optimism Over Phase III Infant RSV Results
BioSpace
Thu, 03/3/22 - 10:24 am
Tags:
Sanofi, AstraZeneca, nirsevimab, vaccines, RSV, clinical trials
Sanofi's net prices keep slipping—despite list price hikes—thanks to billions in rebates
Fierce Pharma
Wed, 03/2/22 - 10:12 pm
Tags:
Sanofi, drug pricing, drug rebates
Sanofi inks an alliance pact with chronic disease-focused digital therapeutics player
Endpoints
Wed, 03/2/22 - 10:11 pm
Tags:
Sanofi, DarioHealth, digital therapeutics, chronic disease
Rare disease and neurology take outs tick higher
EP Vantage
Wed, 03/2/22 - 10:03 am
Tags:
M&A, AbbVie, AstraZeneca, Bristol Myers Squibb, JNJ, Gilead Sciences, Jazz Pharmaceuticals, Merck, Pfizer, Sanofi, rare disease, neurology
Sanofi chases fourth Dupixent nod after late-stage eosinophilic esophagitis trial win
Fierce Pharma
Mon, 02/28/22 - 11:42 pm
Tags:
Sanofi, Regeneron, eosinophilic esophagitis, Dupixent, clinical trials

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.